ERBB2 and colorectal carcinoma: Ivan Borozan et al. investigated 1,994 CRC cases and concluded that mutation status of APC, PIK3CA, KRAS, BRAF, ERBB2, and SMAD4 were not associated with F. nucleatum prevalence31.